Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer
- PMID: 25278712
- PMCID: PMC4177497
- DOI: 10.3748/wjg.v20.i36.13167
Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer
Abstract
Aim: To assess the value of D-dimer level in determining resectability of pancreatic cancer.
Methods: Preoperative prediction of pancreatic head cancer resectability remains inaccurate. The use of hemostatic factors may be of potential help, since D-dimers correlate with tumor stage. Single center clinical trial study comprised patients with potentially resectable pancreatic head tumor and without detectable venous thrombosis (n = 64). Resectability was defined as no evidence of nodal involvement, distant spread and no invasion of mesenteric vessels. Final decision of resectability was confirmed intraoperatively. Experienced pancreatic surgeon performed all surgeries. Following the dissection of hepatoduodenal ligament, samples of portal blood and bile were taken. Peripheral blood via central line and urine via Foley catheter were sampled. D-dimer levels were further measured.
Results: At laparotomy only 29 (45.3%) tumors were found to be resectable. Our analysis showed higher by 57.5% (P < 0.001) mean D-dimer values in peripheral and 43.7% (P = 0.035) in portal blood of patients with unresectable pancreatic cancer. Significant differences were not observed when analyzing D-dimer levels in bile and urine. Peripheral D-dimer level correlated with pancreatic cancer resectability. When cut-off D-dimer value of 570.6 μg/L was used, the sensitivity for assessment of tumor unresectability was 82.8%. Furthermore, D-dimer level in peripheral blood of metastatic disease (n = 15) was significantly higher when compared to locally advanced (n = 20) pancreatic cancer (2470 vs 1168, P = 0.029). The area under ROC curve for this subgroup of patients was 0.87; for determination of unresectable disease when threshold of 769.8 μg/L was used, sensitivity and specificity was 86.6% and 80%, respectively.
Conclusion: Patients with resectable pancreatic head cancer based on preoperative imaging studies and high D-dimer level may be considered unresectable due to occult hepatic metastases. These patients may benefit from diagnostic laparoscopy to avoid exploratory laparotomy.
Keywords: Bile; D-dimers; Pancreatic cancer; Pancreatic cancer respectability; Peripheral blood; Portal blood; Urine.
Figures

Similar articles
-
Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma.World J Surg Oncol. 2017 Feb 20;15(1):48. doi: 10.1186/s12957-017-1104-9. World J Surg Oncol. 2017. PMID: 28219450 Free PMC article.
-
CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients.Pancreatology. 2018 Sep;18(6):666-670. doi: 10.1016/j.pan.2018.07.001. Epub 2018 Jul 3. Pancreatology. 2018. PMID: 30153902
-
Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma.Ann Surg Oncol. 2008 Dec;15(12):3512-20. doi: 10.1245/s10434-008-0134-5. Epub 2008 Sep 10. Ann Surg Oncol. 2008. PMID: 18781364
-
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.Dan Med J. 2012 Dec;59(12):B4568. Dan Med J. 2012. PMID: 23290296 Review.
-
Selection criteria in resectable pancreatic cancer: a biological and morphological approach.World J Gastroenterol. 2014 Aug 28;20(32):11210-5. doi: 10.3748/wjg.v20.i32.11210. World J Gastroenterol. 2014. PMID: 25170205 Free PMC article. Review.
Cited by
-
Gender-Specific Coagulation Profiles of Peripheral and Portal Blood May Help to Differentiate Malignant from Benign Pancreatic Tumour-Pilot Study.J Clin Med. 2022 Mar 13;11(6):1573. doi: 10.3390/jcm11061573. J Clin Med. 2022. PMID: 35329899 Free PMC article.
-
Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma.Clin Appl Thromb Hemost. 2018 Nov;24(8):1267-1275. doi: 10.1177/1076029618779133. Epub 2018 Jun 4. Clin Appl Thromb Hemost. 2018. PMID: 29865859 Free PMC article. Clinical Trial.
-
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis.Int J Clin Oncol. 2024 Apr;29(4):407-416. doi: 10.1007/s10147-024-02475-6. Epub 2024 Mar 2. Int J Clin Oncol. 2024. PMID: 38430303 Free PMC article.
-
Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer.BMC Gastroenterol. 2018 Nov 6;18(1):168. doi: 10.1186/s12876-018-0891-y. BMC Gastroenterol. 2018. PMID: 30400836 Free PMC article.
-
Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection.World J Surg Oncol. 2021 Jun 9;19(1):166. doi: 10.1186/s12957-021-02281-8. World J Surg Oncol. 2021. PMID: 34107980 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Moon HJ, An JY, Heo JS, Choi SH, Joh JW, Kim YI. Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas. 2006;32:37–43. - PubMed
-
- Mann O, Strate T, Schneider C, Yekebas EF, Izbicki JR. Surgery for advanced and metastatic pancreatic cancer--current state and perspectives. Anticancer Res. 2006;26:681–686. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical